SARS-CoV2 / COVID-19 / Corona

The situation regarding COVID-19, especially regarding vaccinations, is very dynamic. We try to keep ourselves and all information here up to date, but ask for your understanding that we can not guarantee the following information.

With the Senate resolution of 29.03. there is from 31.03.2021 in medical facilities such as in public transport and stores the obligation to wear FFP2 masks!

Vaccination in practice

We are now able to provide vaccinations in the office on a limited basis. At the moment we have the vaccine “Comirnaty”(BioNTech/Pfizer). According to the requirements of the KV-Berlin and the Senate, we are initially only allowed to vaccinate existing patients of the office!

Currently and in the near future we have no influence on the available quantities and type or manufacturer of the vaccine. We can therefore only vaccinate what we get. If you would like to influence the type and manufacturer, please make an appointment at a vaccination centre of your choice.

If you are interested in a COVID vaccination in our practice, please send an email to (details: name, date of birth, telephone number, interest in short term follow-up appointments). Please refrain from calling us on this subject, as we are already unable to cope with the general rush in the parallel running of the office!

We will orientate our appointment allocation to the step-by-step schedule of the vaccination ordinance. We would like to point out that vaccination appointments that are not kept cannot be postponed, the vaccination dose will then be administered to available substitutes!

The vaccinations must be carried out by us in addition to the normal practice routine, so that we ask for your understanding that we cannot carry out detailed explanatory talks at the vaccination appointment. Please clarify any questions in advance.

At the vaccination appointment you must be symptom-free and present a completed information sheet. These can be completed as a digital questionnaire or are available for download and self-printing.

Invitation management/attests

The creation and dispatch of vaccination codes for making appointments is carried out exclusively and centrally by the Senate Administration on the basis of the Coronavirus Vaccination Ordinance.

Patients with public health insurance between 65 and 70 years of age who fall under § 3 Abs. 2 of the Coronavirus Vaccination Ordinance do not require a medical certificate to make an appointment for vaccination, as they receive invitation letters via the KV Berlin.

Exception for private patients:
KV Berlin does not have any data on which to base invitations to private patients. The insured persons therefore need a medical certificate in order to arrange the vaccination appointment via the vaccination hotline.

People over 65 who want to be vaccinated with the AstraZeneca vaccine must present a medical certificate; people over 70 only need to present their identity card.

For questions regarding problems with the invitation, individuals can contact the following addresses:
030 / 9028 2828 (daily 8 am -8 pm)

The vaccination hotline for booking a vaccination appointment can be reached at the following telephone number:
030 / 9028 2200

AstraZeneca’s “Vaxzevria”

On Tuesday 30 March 2021, on the advice of the Paul Ehrlich Institute (PEI), due to atypical thromboses (in particular sinus vein thromboses of the brain) observed in temporal connection with the administration of the AstraZeneca vaccine – Vaxzevria (in total approx. 2.8 million vaccinations) in Germany in 31 persons under 60 years of age (9 of them with fatal outcome), the vaccination was suspended for safety reasons for the age group over.

Scientific work in this area is very rare. According to this, sinus vein thromboses occur in 1-2 out of 100,000 people in Germany every year and affect mostly women. Overall, the data situation is uncertain, as there are very likely quite a few clinically inconspicuous cases that are never identified as such.

Thrombosis due to vaccination is therefore an extremely rare side effect. The benefits of vaccination far outweigh this risk, since late sequelae in the neurological and cardiopulmonary systems after COVID-19 disease are not uncommon and can thus only be prevented by vaccination as a precaution. In this respect, vaccination with the AstraZeneca vaccine has not been completely suspended or banned again in Germany after reviews of the reported cases and data by the Paul Ehrlich Institute (PEI, Federal Ministry of Health).

In general: flu-like symptoms such as joint pain, muscle aches and headaches that last for 1-2 days after vaccination are a common side effect (immune reaction) and are not a cause for concern. If side effects persist for more than 3 days after vaccination or occur again (e.g. dizziness, headaches, visual disturbances, shortness of breath, pain in the arms or legs), further medical diagnostics should be made to clarify a thrombosis.

With regard to the second vaccine dose for younger persons (<60 years) who have already received a first dose of the vaccine Vaxzevria (AstraZeneca), there is still no scientific evidence on the safety and effectiveness of a mixed vaccination series. Until corresponding data are available, the STIKO recommends administering a dose of an mRNA vaccine 12 weeks after the first vaccination instead of the second Vaxzevria vaccine dose from AstraZeneca for persons <60 years. Furthermore, the STIKO recommends a study investigating immunological effects following the heterologous vaccination schedule.

Vaccine Clearing Unit

The Vaccination Clearing Unit has been created for special cases of hardship. After an individual medical assessment, a decision is made as to whether the circumstances of the individual case allow the applicant to be vaccinated as a matter of priority. This concerns pre-existing diseases and clinical pictures not expressly covered by the vaccination ordinance of the Federal Ministry of Health, which justify a decision on a case-by-case basis.

The Vaccine Clearing Unit can be reached by e-mail at

Rapid tests

According to the Senate Health Administration (07.03.2021), symptom-free Berliners are requested to be tested once a week with a rapid test (PoC) for their personal protection and for the protection of their own environment. You will receive a test certificate for this and the tests should be free of charge.

We do NOT offer these free tests!

You can find an overview of the rapid test centres set up by the Senate (opening hours: 9 am – 5 pm) here:

Charlottenburg-Wilmersdorf: Zillestraße. 10, 10585 Berlin
Friedrichshain-Kreuzberg: Prinzenstr. 23, 10969 Berlin
Lichtenberg: Rummelsburger Str. 13, 10315 Berlin
Marzahn-Hellersdorf: Janusz-Korczak Str. 17. 12627 Berlin
Neukölln: Bat-Yam-Platz 1, 12353 Berlin
Pankow: Hauptstr. 29a, 12158 Berlin
Reinickendorf: Antonienstr. 51, 13403 Berlin
Spandau: Schönwalder Allee 26 13587 Berlin (Hintereingang Haus 2)
Steglitz-Zehlendorf: Kirchstr. 1-3, 14163 Berlin
Tempelhof-Schöneberg: Mariendorfer Damm 64, 12109 Berlin
Treptow-Köpenick: Spreestraße. 6, 12439 Berlin
Wedding: Müllerstraße 146, 13353 Berlin

In addition to this Berlin test centres, a broad network of “Test-To-Go-Stations” should be established.

If you have symptoms, please contact the Corona test centres or special Corona practices.

COVID-19 vaccines and modes of action

mRNA vaccine: BioNTech, Moderna, Curevac
Vector vaccine: AstraZeneca, Johnson & Johnson, Sputnik V, CanSino Biologics
Inactivated vaccine: Novavax, Sinopharm, Sinova

Vaccines with vector viruses use harmless viruses as carriers of genetic information of the actual virus. Information about certain proteins is incorporated into the genetic material of these vector viruses (carrier viruses). The aim is to make the immune system form antibodies against these proteins and to trigger other defence reactions. Upon contact with the actual virus, the body is then prepared and can better contain the infection.

Vaccines made with messenger RNA (mRNA) this is a new concept. No weakened virus or individual parts of a virus are used for vaccination. Instead, the vaccine consists only of genetic information in the form of messenger RNA or mRNA. The RNA molecules contain blueprints for proteins that the vaccinated person’s body is supposed to produce itself.

Vaccines made from viral protein are classic vaccines (such as tetanus or flu vaccines) that are based on inactivated pathogens.

All 4 vaccines approved in Germany (BioNTech, Moderna, AstraZeneca, Johnson&Johnson) show a very good protective effect against severe diseases. Despite minor differences between the vaccines, there is no reason to be choosy, according to vaccination experts. As long as there are not enough vaccines for everyone, the first vaccine is always the best.

How long can a potential vaccine protect?
Results from several teams show that the number of neutralising antibodies drops significantly after a few months. Especially infected people without or with only minor symptoms of the disease then have hardly any protective antibodies left. There is currently no reliable information on how good the immunity still is after months or years. The virus is still too new to be able to judge.

Can vaccinated people infect others?
Study results suggest that the vaccines not only protect against infection and severe courses of the disease, but also that vaccinated people are much less likely to pass on the virus.

People after SARS-CoV2 infection should receive a single vaccination no earlier than 6 months after diagnosis.